Agape ATP Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Agape ATP Corp Unternehmen

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.

Agape ATP Corp Informationen



BörsenkürzelATPC

Name des UnternehmensAgape ATP Corp

IPO-datumSep 17, 2018

CEOHow (Kok Choong)

Anzahl der mitarbeiter16

WertpapierartOrdinary Share

GeschäftsjahresendeSep 17

Addresse1705-1708 Level 17, Tower 2, Faber Tower

StadtKUALA LUMPUR

BörseNASDAQ OMX - NASDAQ BASIC

LandMalaysia

Postleitzahl58100

Telefon60327325716

Websitehttps://www.agapeatpgroup.com/index_php

BörsenkürzelATPC

IPO-datumSep 17, 2018

CEOHow (Kok Choong)

Führungskräfte von Agape ATP Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Kam Fan (Andrew) Lee

Chief Financial Officer

--

Mr. Tjong Budisantoso, Ph.D.

Executive Director

--

Dr. Wilfrendo Fernando Cortizo, Ph.D.

Director

--

Dr. Ni Luh Dharmakert Natih

Independent Director

--

Ms. Rose Marie Kadende Marie Kadende Kaiser

Independent Director

--

Dr. Kok Choong How

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Kam Fan (Andrew) Lee

Chief Financial Officer

--

Mr. Tjong Budisantoso, Ph.D.

Executive Director

--

Dr. Wilfrendo Fernando Cortizo, Ph.D.

Director

--

Dr. Ni Luh Dharmakert Natih

Independent Director

--

Ms. Rose Marie Kadende Marie Kadende Kaiser

Independent Director

--

Dr. Kok Choong How

Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary

--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Others – Products for the provision of complementary health therapies

222.64K

60.08%

Skin care and healthcare products

90.56K

24.44%

Health and wellness services

38.93K

10.51%

Energized Mineral Concentrate

15.81K

4.27%

Green energy

1.27K

0.34%

Andere

1.37K

0.37%

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Others – Products for the provision of complementary health therapies

222.64K

60.08%

Skin care and healthcare products

90.56K

24.44%

Health and wellness services

38.93K

10.51%

Energized Mineral Concentrate

15.81K

4.27%

Green energy

1.27K

0.34%

Andere

1.37K

0.37%

Aktionärsstatistik

Aktualisiert: Mon, Jan 12

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Lesser Panda Ltd

7.36%

Global Fartech Ltd

6.90%

Nexus Investments Group Ltd

6.07%

Oceanic Equity Partner Ltd

6.06%

Blue Horizon Capital Ltd

6.05%

Andere

67.57%

Aktionäre

Anteil

Lesser Panda Ltd

7.36%

Global Fartech Ltd

6.90%

Nexus Investments Group Ltd

6.07%

Oceanic Equity Partner Ltd

6.06%

Blue Horizon Capital Ltd

6.05%

Andere

67.57%

Aktionärstypen

Aktionäre

Anteil

Corporation

50.53%

Individual Investor

2.04%

Hedge Fund

0.15%

Venture Capital

0.02%

Andere

47.26%

Institutionelle Beteiligung



Aktualisiert: Mon, Dec 8

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

12

96.83K

0.35%

--

2025Q3

12

96.83K

0.35%

-72.67K

2025Q2

11

169.49K

0.02%

+164.03K

2025Q1

9

5.47K

0.16%

-73.08K

2024Q4

8

71.66K

0.86%

+46.14K

2024Q3

8

25.52K

0.25%

+18.90K

2024Q2

7

6.62K

0.25%

-3.05K

2024Q1

6

9.68K

0.06%

+7.38K

2023Q4

1

578.00

0.00%

+578.00

2023Q3

2

1.39M

36.92%

--

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Lesser Panda Ltd

3.68M

7.36%

+3.68M

--

Mar 24, 2025

Global Fartech Ltd

3.45M

6.9%

+3.45M

--

Mar 24, 2025

Nexus Investments Group Ltd

3.04M

6.07%

+3.04M

--

Mar 24, 2025

Oceanic Equity Partner Ltd

3.03M

6.06%

+3.03M

--

Mar 24, 2025

Blue Horizon Capital Ltd

3.03M

6.05%

+3.03M

--

Mar 24, 2025

Global Ascend Ventures Ltd

3.02M

6.04%

+3.02M

--

Mar 24, 2025

Vanguard Development Holdings Ltd

3.02M

6.03%

+3.02M

--

Mar 24, 2025

Evergreen Strategic Capital Holding Ltd

3.01M

6.02%

+3.01M

--

Mar 24, 2025

Choong (How Kok)

980.45K

1.96%

+574.00

+0.06%

Jan 08, 2025

Citadel Advisors LLC

65.13K

0.13%

+31.85K

+95.70%

Sep 30, 2025

Verbundene ETFs



Name

Anteil

Keine Daten

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Jan 09, 2026

Merger

50→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Datum

Ex-Dividendentag

Art

Verhältnis

Jan 09, 2026

Merger

50→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1

Aug 28, 2024

Merger

20→1